Esperion Therapeutics: Q2 Earnings Snapshot

ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Tuesday reported a second-quarter loss of $43.7 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $1.67.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.82 per share.

The biopharmaceutical company posted revenue of $40.7 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $41.1 million.

Esperion Therapeutics shares have decreased 42% since the beginning of the year. The stock has dropped 60% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR

Categories: Business News